secwatch.observer — SEC 8-K summary
======================================

Issuer:     NKGen Biotech, Inc. (—)
CIK:        0001845459
Form:       8-K
Filed at:   2024-08-21T23:59:59+00:00
Accession:  0001213900-24-071450
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

NKGen Biotech COO Pierre Gagnon resigns, stays as advisor through Nov 30
------------------------------------------------------------------------

- Pierre Gagnon resigned as COO effective August 15, 2024; will remain as non-executive employee in transition role until November 30, 2024.
- Resignation not due to any disagreements with the Company regarding operations, policies, or practices.
- No successor has been named as of the filing date.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1845459/000121390024071450/0001213900-24-071450-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1845459/000121390024071450/ea0211985-8k_nkgen.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-071450

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer